• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

作者更正：作为治疗2型糖尿病的有效葡萄糖激酶激活剂的吡哆醇双药效团衍生物。

Author Correction: Pyridoxine dipharmacophore derivatives as potent glucokinase activators for the treatment of type 2 diabetes mellitus.

作者信息

Dzyurkevich Mikhail S, Babkov Denis A, Shtyrlin Nikita V, Mayka Olga Yu, Iksanova Alfiya G, Vassiliev Pavel M, Balakin Konstantin V, Spasov Alexander A, Tarasov Vadim V, Barreto George, Shtyrlin Yurii G, Aliev Gjumrakch

机构信息

Kazan (Volga region) Federal University, Kremlyovskaya 18, Kazan, 420008, Russia.

Volgograd State Medical University, Pavshikh Bortsov Sq. 1, Volgograd, 400131, Russia.

出版信息

Sci Rep. 2018 Apr 19;8(1):6489. doi: 10.1038/s41598-018-24838-6.

DOI:10.1038/s41598-018-24838-6
PMID:29670171
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5906454/
Abstract

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.

摘要

本文的一篇更正已发表，并可从本文的HTML和PDF版本链接。该错误尚未在纸质版中更正。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a1e/5906454/33188aa0ba81/41598_2018_24838_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a1e/5906454/33188aa0ba81/41598_2018_24838_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a1e/5906454/33188aa0ba81/41598_2018_24838_Fig1_HTML.jpg

相似文献

1
Author Correction: Pyridoxine dipharmacophore derivatives as potent glucokinase activators for the treatment of type 2 diabetes mellitus.作者更正：作为治疗2型糖尿病的有效葡萄糖激酶激活剂的吡哆醇双药效团衍生物。
Sci Rep. 2018 Apr 19;8(1):6489. doi: 10.1038/s41598-018-24838-6.
2
Pyridoxine dipharmacophore derivatives as potent glucokinase activators for the treatment of type 2 diabetes mellitus.二氢吡啶药效团衍生物作为治疗 2 型糖尿病的有效葡萄糖激酶激活剂。
Sci Rep. 2017 Nov 22;7(1):16072. doi: 10.1038/s41598-017-16405-2.
3
Author Correction: Analysis of inflammatory cytokine and TLR expression levels in Type 2 Diabetes with complications.作者更正：2型糖尿病合并并发症时炎症细胞因子和Toll样受体表达水平分析
Sci Rep. 2018 Apr 5;8(1):5768. doi: 10.1038/s41598-018-23475-3.
4
Author Correction: Evaluation of Hypoglycaemia with Non-Invasive Sensors in People with Type 1 Diabetes and Impaired Awareness of Hypoglycaemia.作者更正：使用非侵入性传感器评估1型糖尿病合并低血糖意识受损患者的低血糖情况。
Sci Rep. 2019 Apr 16;9(1):6347. doi: 10.1038/s41598-019-42218-6.
5
Author Correction: Genetic markers for urine haptoglobin is associated with decline in renal function in type 2 diabetes in East Asians.作者更正：东亚2型糖尿病患者尿触珠蛋白的遗传标记与肾功能下降有关。
Sci Rep. 2018 Sep 7;8(1):13718. doi: 10.1038/s41598-018-31990-6.
6
Author Correction: A quantitative study on growth variability and production of ochratoxin A and its derivatives by A. carbonarius and A. niger in grape-based medium.作者更正：关于葡萄基培养基中碳黑曲霉和黑曲霉生长变异性以及赭曲霉毒素A及其衍生物产生情况的定量研究。
Sci Rep. 2019 Apr 26;9(1):6803. doi: 10.1038/s41598-019-42136-7.
7
Author Correction: Extraordinarily potent proinflammatory properties of lactoferrin-containing immunocomplexes against human monocytes and macrophages.作者更正：含乳铁蛋白的免疫复合物对人单核细胞和巨噬细胞具有极强的促炎特性。
Sci Rep. 2018 Nov 16;8(1):17225. doi: 10.1038/s41598-018-35598-8.
8
Author Correction: Determinants of Quantitative Optical Coherence Tomography Angiography Metrics in Patients with Diabetes.
Sci Rep. 2018 May 4;8(1):7314. doi: 10.1038/s41598-018-25619-x.
9
Author Correction: Closed-type pre-treatment device for point-of-care testing of sputum.作者更正：用于痰液即时检测的封闭式预处理装置。
Sci Rep. 2018 Dec 17;8(1):17994. doi: 10.1038/s41598-018-36359-3.
10
Author Correction: Pessimism and fearfulness in dairy calves.作者更正：犊牛的悲观情绪和恐惧心理。
Sci Rep. 2018 Sep 26;8(1):14594. doi: 10.1038/s41598-018-32321-5.